Macromolecular prodrugs. XII. Primaquine conjugates: Synthesis and preliminary antimalarial evaluation

S. Vangapandu, S. Sachdeva, M. Jain, S. Singh, P. P. Singh, C. L. Kaul and R. Jain, 8-Quinolinamines and their pro prodrug conjugates as potent blood-schizontocidal antimalarial agents, Bioorg. Med. Chem. 11 (2003) 4557-4568; DOI: 10.1016/j.bmc.2003.07.003.10.1016/j.bmc.2003.07.003Search in Google Scholar

N. Vale, R. Moreira and P. Gomes, Primaquine revisited six decades after its discovery, Eur. J. Med. Chem. (2008) (in press); DOI: 10.1016/j.ejmech.2008.08.011.10.1016/j.ejmech.2008.08.011Search in Google Scholar

R. Jain, S. Jain, R. C. Gupta, N. Anand, G. P. Dutta and S. K. Puri, Synthesis of amino acid derivatives of 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-substituted/4,5-disubstituted-quinolines as potential antimalarial agents, Ind. J. Chem. 33B (1994) 251-254.Search in Google Scholar

M. Jain, S. Vangapandu, S. Sachdeva and R. Jain, Synthesis and blood-schizontocidal antimalarial activities of 2-substituted/2,5-disubstituted-8-quinolinamines and some of their amino acid conjugates, Bioorg. Med. Chem. 12 (2004) 1003-1010; DOI 10.1016/j.bmc.2003.12.029.10.1016/j.bmc.2003.12.029Search in Google Scholar

R. Borissova, P. Stjärnkvist, M. O. Karlsson and I. Sjöholm, Biodegradable microspheres. 17. Lysosomal degradation of primaquine-peptide spacer arms, J. Pharm. Sci. 84 (1995) 256-262.10.1002/jps.2600840227Search in Google Scholar

P. Stjärnkvist, Biodegradable microspheres: XIV. Effect of microparticle-bound primaquine on L. donovani in mice, Int. J. Pharm. 96 (1993) 23-32; DOI: 10.1016/0378-5173(93)90208-W.10.1016/0378-5173(93)90208-WSearch in Google Scholar

A. Trouet, P. Pirson, R. Baurain and M. Masquelier, Cell Targeting of Primaquine, in Handbook of Experimental Pharmacology, Vol. 68, Part 2, Springer-Verlag, Berlin 1984, pp. 253-264.10.1007/978-3-642-69254-3_8Search in Google Scholar

R. Duncan, Polymer-drug Conjugates: Targeting Cancer, in Biomedical Aspects of Drug Targeting (Eds. V. Muzykantov and V. Torchilin), Kluwer Academic Publishers, Norwell 2002, pp. 193-209.10.1007/978-1-4757-4627-3_10Search in Google Scholar

R. Duncan, The dawning era of polymer therapeutics, Drug Discovery 2 (2003) 347-360; DOI: 10.1038/nrd1088.10.1038/nrd1088Search in Google Scholar

P. Mayorga, E. Deharo, F. Puisieux and G. Couarraze, Interpretation and prediction of plasma levels of primaquine following transdermal delivery in Swiss mice, Int. J. Pharm. 155 (1997) 99-107.10.1016/S0378-5173(97)00151-8Search in Google Scholar

A. A. Date, M. D. Joshi and V. B. Patravale, Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles, Adv. Drug Deliv. Rev. 59 (2007) 505-521; DOI: 10.1016/j.addr.2007.04.009.10.1016/j.addr.2007.04.00917574295Search in Google Scholar

A. M. Dierling and Z. Cui, Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy, Int. J. Pharm. 303 (2005) 143-152; DOI: 10.1016/j.ijpharm.2005.07.015.10.1016/j.ijpharm.2005.07.015Search in Google Scholar

G. Džimbeg, B. Zorc, M. Kralj, K. Ester, K. Pavelić, J. Balzarini, E. De Clercq and M. Mintas, The novel primaquine derivatives of N-alkyl, cycloalkyl or aryl urea: synthesis, cytostatic and antiviral activity evaluations, Eur. J. Med. Chem. 43 (2008) 1180-1187; DOI: 10.1016/j.ejmech.2007.09.001.10.1016/j.ejmech.2007.09.001Search in Google Scholar

J. Vlasák, F. Rypáček, J. Drobník and V. Saudek, Properties and reactivity of polysuccinimide, J. Polym. Sci. Polym. Symp. 66 (1979) 59-64.10.1002/polc.5070660109Search in Google Scholar

M. Lovrek, B. Zorc, B. Boneschans and I. Butula, Macromolecular prodrugs. VIII. Polymer-gemfibrozil conjugates, Int. J. Pharm. 200 (2000) 59-66; DOI: 10.1016/S0378-5173(00)00340-9.10.1016/S0378-5173(00)00340-9Search in Google Scholar

G. Antoni, C. Arezzini, F. Cocola, G. Gazzei and P. Neri, Pharmacological and toxicological evaluation of polyhydroxyethylaspartamide (PHEA) as a plasma substitute, Farmaco Ed. Pr. 34 (1979) 146-156.Search in Google Scholar